Ivonescimab Before Surgery for the Treatment of Resectable Stage II-IV Head and Neck Cancer

Clinical trial NCT07094685 · RECRUITING

Trial details

NCT number: NCT07094685
Sponsor: University of Michigan Rogel Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Head and Neck Squamous Cell Carcinoma Resectable Head and Neck Squamous Cell Carcinoma Stage II Head and Neck Cutaneous Squamous Cell Carcinoma Stage III Head and Neck Cutaneous Squamous Cell Carcinoma Stage IV Head and Neck Cutaneous Squamous Cell Carcinoma

Start date: 2025-11-18
Primary completion: 2027-08-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.